HIGHBRIDGE CAPITAL MANAGEMENT LLC 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 10:11 am Purchase |
2024-09-30 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3,062,690 9.200% |
3,062,690 (New Position) |
Filing |